CATALOGO DEI PRODOTTI DELLA RICERCA

ZANOTTI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.146
EU - Europa 4.723
AS - Asia 3.442
SA - Sud America 389
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 79
OC - Oceania 18
Totale 13.902
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.058
RU - Federazione Russa 1.647
SG - Singapore 1.228
CN - Cina 1.206
GB - Regno Unito 1.106
IT - Italia 436
SE - Svezia 347
VN - Vietnam 304
BR - Brasile 290
DE - Germania 272
HK - Hong Kong 252
FR - Francia 235
IE - Irlanda 207
FI - Finlandia 199
BD - Bangladesh 105
KR - Corea 98
UA - Ucraina 54
NL - Olanda 50
CA - Canada 49
IN - India 48
TR - Turchia 36
AR - Argentina 35
BE - Belgio 33
JP - Giappone 32
PL - Polonia 29
ID - Indonesia 28
ES - Italia 25
ZA - Sudafrica 21
MX - Messico 20
AT - Austria 19
NG - Nigeria 19
AU - Australia 16
EC - Ecuador 14
IQ - Iraq 14
UZ - Uzbekistan 13
CL - Cile 12
VE - Venezuela 12
PK - Pakistan 10
CO - Colombia 9
MA - Marocco 9
LT - Lituania 8
MY - Malesia 8
CH - Svizzera 7
CZ - Repubblica Ceca 6
DK - Danimarca 6
IR - Iran 6
RO - Romania 6
TN - Tunisia 6
AZ - Azerbaigian 5
BO - Bolivia 5
GR - Grecia 5
PE - Perù 5
PY - Paraguay 5
DZ - Algeria 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
PT - Portogallo 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
BJ - Benin 3
CR - Costa Rica 3
HR - Croazia 3
NO - Norvegia 3
NP - Nepal 3
PH - Filippine 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
CG - Congo 2
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KH - Cambogia 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BT - Bhutan 1
CD - Congo 1
CY - Cipro 1
Totale 13.783
Salva come PNG Salva come JPEG
Città #
Southend 928
Singapore 647
Ashburn 585
Moscow 570
Chandler 511
San Jose 448
Dallas 409
Jacksonville 321
Woodbridge 304
Ann Arbor 293
Beijing 289
Hong Kong 249
Dublin 205
Houston 164
The Dalles 155
New York 142
Verona 132
Wilmington 107
Jinan 88
Ho Chi Minh City 85
Los Angeles 84
Council Bluffs 81
Lawrence 80
Princeton 80
Hanoi 74
Nanjing 65
Munich 58
Helsinki 57
Shenyang 55
Bologna 41
Tianjin 41
Hebei 39
São Paulo 38
Columbus 37
Buffalo 36
Ningbo 34
Brussels 33
Santa Clara 33
Changsha 31
Zhengzhou 31
Milan 30
Hangzhou 29
Taizhou 29
Tokyo 29
Boardman 28
Haikou 28
Guangzhou 27
Redondo Beach 26
Manchester 25
Turku 24
Chicago 23
Warsaw 23
Denver 22
Groningen 22
Chennai 21
Nanchang 21
Sindelfingen 21
Frankfurt am Main 19
Norwalk 18
Seattle 18
Atlanta 17
Jiaxing 17
Montreal 17
London 16
Orem 16
Rome 16
Stockholm 16
Taiyuan 16
Dearborn 15
Redwood City 15
Seoul 15
Vienna 15
Abuja 14
Haiphong 14
Johannesburg 14
Falls Church 13
Lancaster 13
Phoenix 13
Boston 12
San Francisco 12
Tashkent 12
Amsterdam 11
Brooklyn 11
Dong Ket 11
Falkenstein 11
Jakarta 11
Fuzhou 10
Lanzhou 10
Mexico City 10
Poplar 10
Augusta 9
Biên Hòa 9
Shanghai 9
Toronto 9
Turin 9
Belo Horizonte 8
Charlotte 8
Düsseldorf 8
Fairfield 8
Redmond 8
Totale 8.631
Salva come PNG Salva come JPEG
Nome #
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 335
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 266
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 257
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 256
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 250
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 249
BCR-signaling profiles associated with prognosis and progression in B-CLL 235
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 230
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 227
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 223
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 221
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected 221
BCR-signaling profiles associated with prognosis and progression in B-CLL 220
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 218
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 216
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 216
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 215
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 210
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 207
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 207
Bone involvement and osteoporosis in mastocytosis. 203
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 200
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 200
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 192
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 191
Bone involvement in patient with clonal mast cell disorders 190
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 188
The high oxygen affinity haemoglobin Nantes: a family case description 188
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 187
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 182
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 182
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 181
Osteopetrosi 180
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 176
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 174
Bone Disease in Mastocytosis 171
Underdiagnosed systemic mastocytosis: The role of flow cytometry 170
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 168
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 167
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders 165
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 165
Effects of denosumab on peripheral lymphocyte subpopulations 163
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 160
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 160
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 159
Ultra-deep sequencing (UDS) allows more sensitive detection of the D816V and other KIT gene mutations in systemic mastocytosis 158
Vaccination Management In Children and Adults With Mastocytosis 158
Prevalence of osteoporosis in patients affected by mastocytosis 157
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 157
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 156
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry 155
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 147
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms 146
Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association 146
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 144
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 144
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 143
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation 140
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series 138
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission 135
Mastocytosis and allergic diseases 135
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia 133
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study 133
Single Cell Network Profiling (SCNP) assay reveals B Cell Receptor Signaling heterogeneity in the Context of ZAP-70 Expression in patients with Chronic Lymphocytic Leukemia (CLL) 132
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification 132
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 131
Systemic Mastocytosis 130
Skeletal implications of isolated bone marrow mastocytosis (reply): Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis (reply) 127
Mast Cell Disorders In Drug Hypersensitivity 126
Male osteoporosis and hymenoptera venom anaphylaxis [Osteoporosi maschile e anafilassi da imenotteri] 124
Rapid skeletal turnover in radiographic mimic of osteopetrosis might be secondary to systemic mastocytosis [corrected] 119
Hymenoptera Allergy and Mast Cell Activation Syndromes 117
Mastocytosis and insect venom allergy 103
Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis. 102
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives 101
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 96
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 94
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM 94
Occupational exposure to glyphosate and risk of lymphoma:results of an Italian multicenter case-control study 73
Night shift work and lymphoma: results from an Italian multicentre case-control study 70
Letter to the Editor: Rapid Skeletal Turnover in a Radiographic Mimic of Osteopetrosis Might Be Secondary to Systemic Mastocytosis 68
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis 50
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis 47
null 44
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 31
Occupational exposure to formaldehyde and risk of lymphoma subtypes: results of a multicentre Italian case-control study 21
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM 4
Totale 13.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.539
article - articoli 31.292
book - libri 0
conference - conferenze 13.247
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022689 0 237 8 91 42 19 21 42 35 22 39 133
2022/20231.442 92 170 114 292 92 362 30 76 163 10 26 15
2023/2024773 57 66 47 69 88 132 37 71 5 39 123 39
2024/20251.771 85 126 98 300 80 47 78 62 287 124 160 324
2025/20265.619 379 301 405 897 1.362 376 508 276 444 359 168 144
2026/2027113 90 23 0 0 0 0 0 0 0 0 0 0
Totale 13.902